Personalised first line treatment of advanced NSCLC

In this review:

Epidemiology of lung cancer
Treatment of advanced (stage IIIB-IV) NSCLC
EGFR-targeted chemotherapy
Other molecular targets for chemotherapy
Role of EGFR mutation status in determining first-line NSCLC treatment
European and US lung cancer guidelines on testing for EGFR mutation status
Sampling requirements for successful EGFR mutation testing
Multidisciplinary approach to diagnosis and treatment of lung cancer

Download PDF Subscribe